Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-23

Clinical Trial Update: A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy of early versus late use of vedolizumab in Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vedolizumab (vedolizumab)

Snippet

Sponsor: Geert D'Haens | Conditions: Crohn Disease | Phase 4 | Status: COMPLETED